173 related articles for article (PubMed ID: 31956003)
21. Intratumoral CD3 and CD8 T-cell Densities Associated with Relapse-Free Survival in HCC.
Gabrielson A; Wu Y; Wang H; Jiang J; Kallakury B; Gatalica Z; Reddy S; Kleiner D; Fishbein T; Johnson L; Island E; Satoskar R; Banovac F; Jha R; Kachhela J; Feng P; Zhang T; Tesfaye A; Prins P; Loffredo C; Marshall J; Weiner L; Atkins M; He AR
Cancer Immunol Res; 2016 May; 4(5):419-30. PubMed ID: 26968206
[TBL] [Abstract][Full Text] [Related]
22. Association of tumour-infiltrating regulatory T cells with adverse outcomes in dogs with malignant tumours.
Sakai K; Maeda S; Yamada Y; Chambers JK; Uchida K; Nakayama H; Yonezawa T; Matsuki N
Vet Comp Oncol; 2018 Sep; 16(3):330-336. PubMed ID: 29322606
[TBL] [Abstract][Full Text] [Related]
23. Non-thermal irreversible electroporation (N-TIRE) and adjuvant fractionated radiotherapeutic multimodal therapy for intracranial malignant glioma in a canine patient.
Garcia PA; Pancotto T; Rossmeisl JH; Henao-Guerrero N; Gustafson NR; Daniel GB; Robertson JL; Ellis TL; Davalos RV
Technol Cancer Res Treat; 2011 Feb; 10(1):73-83. PubMed ID: 21214290
[TBL] [Abstract][Full Text] [Related]
24. Ablation of colorectal liver metastases by irreversible electroporation: results of the COLDFIRE-I ablate-and-resect study.
Scheffer HJ; Nielsen K; van Tilborg AA; Vieveen JM; Bouwman RA; Kazemier G; Niessen HW; Meijer S; van Kuijk C; van den Tol MP; Meijerink MR
Eur Radiol; 2014 Oct; 24(10):2467-75. PubMed ID: 24939670
[TBL] [Abstract][Full Text] [Related]
25. Irreversible Electroporation for Treatment of Hepatocellular Carcinoma Adjacent to the Gallbladder.
Herwald SE; Chen JH; Arellano RS
J Vasc Interv Radiol; 2016 Jul; 27(7):1093-4. PubMed ID: 27338501
[No Abstract] [Full Text] [Related]
26. Safety and feasibility of the NanoKnife system for irreversible electroporation ablative treatment of canine spontaneous intracranial gliomas.
Rossmeisl JH; Garcia PA; Pancotto TE; Robertson JL; Henao-Guerrero N; Neal RE; Ellis TL; Davalos RV
J Neurosurg; 2015 Oct; 123(4):1008-25. PubMed ID: 26140483
[TBL] [Abstract][Full Text] [Related]
27. Irreversible Electroporation for Unresectable Hepatocellular Carcinoma: Initial Experience.
Kalra N; Gupta P; Gorsi U; Bhujade H; Chaluvashetty SB; Duseja A; Singh V; Dhiman RK; Chawla YK; Khandelwal N
Cardiovasc Intervent Radiol; 2019 Apr; 42(4):584-590. PubMed ID: 30697637
[TBL] [Abstract][Full Text] [Related]
28. Association Between Expression Level of PD1 by Tumor-Infiltrating CD8
Kim HD; Song GW; Park S; Jung MK; Kim MH; Kang HJ; Yoo C; Yi K; Kim KH; Eo S; Moon DB; Hong SM; Ju YS; Shin EC; Hwang S; Park SH
Gastroenterology; 2018 Dec; 155(6):1936-1950.e17. PubMed ID: 30145359
[TBL] [Abstract][Full Text] [Related]
29. Single-center nonrandomized clinical trial to assess the safety and efficacy of irreversible electroporation (IRE) ablation of liver tumors in humans: Short to mid-term results.
Frühling P; Nilsson A; Duraj F; Haglund U; Norén A
Eur J Surg Oncol; 2017 Apr; 43(4):751-757. PubMed ID: 28109674
[TBL] [Abstract][Full Text] [Related]
30. Antibodies Against Immune Checkpoint Molecules Restore Functions of Tumor-Infiltrating T Cells in Hepatocellular Carcinomas.
Zhou G; Sprengers D; Boor PPC; Doukas M; Schutz H; Mancham S; Pedroza-Gonzalez A; Polak WG; de Jonge J; Gaspersz M; Dong H; Thielemans K; Pan Q; IJzermans JNM; Bruno MJ; Kwekkeboom J
Gastroenterology; 2017 Oct; 153(4):1107-1119.e10. PubMed ID: 28648905
[TBL] [Abstract][Full Text] [Related]
31. Activation and dramatically increased cytolytic activity of tumor specific T lymphocytes after radio-frequency ablation in patients with hepatocellular carcinoma and colorectal liver metastases.
Hansler J; Wissniowski TT; Schuppan D; Witte A; Bernatik T; Hahn EG; Strobel D
World J Gastroenterol; 2006 Jun; 12(23):3716-21. PubMed ID: 16773688
[TBL] [Abstract][Full Text] [Related]
32. Lymphopenia predicts reduced survival in canine hepatocellular carcinoma.
Suarez-Rodriguez JI; Liu CC; Dehghanpir S; Johnston AN
J Vet Sci; 2023 May; 24(3):e36. PubMed ID: 37271504
[TBL] [Abstract][Full Text] [Related]
33. Tumour lymphocytic infiltrate and recurrence of hepatocellular carcinoma following liver transplantation.
Unitt E; Marshall A; Gelson W; Rushbrook SM; Davies S; Vowler SL; Morris LS; Coleman N; Alexander GJ
J Hepatol; 2006 Aug; 45(2):246-53. PubMed ID: 16580084
[TBL] [Abstract][Full Text] [Related]
34. Factors associated with short-term local recurrence of liver cancer after percutaneous ablation using irreversible electroporation: a prospective single-center study.
Niessen C; Igl J; Pregler B; Beyer L; Noeva E; Dollinger M; Schreyer AG; Jung EM; Stroszczynski C; Wiggermann P
J Vasc Interv Radiol; 2015 May; 26(5):694-702. PubMed ID: 25812712
[TBL] [Abstract][Full Text] [Related]
35. Expression and function of CXC and CC chemokines in human malignant liver tumors: a role for human monokine induced by gamma-interferon in lymphocyte recruitment to hepatocellular carcinoma.
Yoong KF; Afford SC; Jones R; Aujla P; Qin S; Price K; Hubscher SG; Adams DH
Hepatology; 1999 Jul; 30(1):100-11. PubMed ID: 10385645
[TBL] [Abstract][Full Text] [Related]
36. Expression of co-stimulator 4-1BB molecule in hepatocellular carcinoma and adjacent non-tumor liver tissue, and its possible role in tumor immunity.
Wan YL; Zheng SS; Zhao ZC; Li MW; Jia CK; Zhang H
World J Gastroenterol; 2004 Jan; 10(2):195-9. PubMed ID: 14716821
[TBL] [Abstract][Full Text] [Related]
37. Reliability of a single-region sample to evaluate tumor immune microenvironment in hepatocellular carcinoma.
Shen YC; Hsu CL; Jeng YM; Ho MC; Ho CM; Yeh CP; Yeh CY; Hsu MC; Hu RH; Cheng AL
J Hepatol; 2020 Mar; 72(3):489-497. PubMed ID: 31634533
[TBL] [Abstract][Full Text] [Related]
38. Percutaneous ablation therapy of hepatocellular carcinoma with irreversible electroporation: MRI findings.
Granata V; Fusco R; Catalano O; Piccirillo M; De Bellis M; Izzo F; Petrillo A
AJR Am J Roentgenol; 2015 May; 204(5):1000-7. PubMed ID: 25905934
[TBL] [Abstract][Full Text] [Related]
39. Canine hepatocellular carcinoma.
Patnaik AK; Hurvitz AI; Lieberman PH; Johnson GF
Vet Pathol; 1981 Jul; 18(4):427-38. PubMed ID: 6266116
[TBL] [Abstract][Full Text] [Related]
40. Pulmonary Hemorrhage during Irreversible Electroporation of Hepatocellular Carcinoma.
Hoffer EK; Shelton TW; Ring NY
J Vasc Interv Radiol; 2019 Jun; 30(6):970-972.e1. PubMed ID: 31126611
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
